U.S. markets close in 5 hours 3 minutes
  • S&P 500

    -93.19 (-2.35%)
  • Dow 30

    -463.67 (-1.45%)
  • Nasdaq

    -418.20 (-3.63%)
  • Russell 2000

    -48.53 (-2.71%)
  • Crude Oil

    +0.17 (+0.15%)
  • Gold

    +15.80 (+0.86%)
  • Silver

    +0.34 (+1.55%)

    +0.0032 (+0.30%)
  • 10-Yr Bond

    -0.1240 (-4.34%)

    -0.0062 (-0.49%)

    -1.4090 (-1.10%)

    -1,289.48 (-4.27%)
  • CMC Crypto 200

    -11.22 (-1.71%)
  • FTSE 100

    -28.63 (-0.38%)
  • Nikkei 225

    -253.38 (-0.94%)
WEF 2022:

Yahoo Finance is in Davos! Get the latest updates here

Introducing Medpace Holdings (NASDAQ:MEDP), The Stock That Zoomed 174% In The Last Three Years

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes to zero. But in contrast you can make much more than 100% if the company does well. For instance the Medpace Holdings, Inc. (NASDAQ:MEDP) share price is 174% higher than it was three years ago. That sort of return is as solid as granite. It's also good to see the share price up 30% over the last quarter.

Check out our latest analysis for Medpace Holdings

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

During three years of share price growth, Medpace Holdings achieved compound earnings per share growth of 162% per year. The average annual share price increase of 40% is actually lower than the EPS growth. So one could reasonably conclude that the market has cooled on the stock.

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

NasdaqGS:MEDP Past and Future Earnings, February 24th 2020
NasdaqGS:MEDP Past and Future Earnings, February 24th 2020

We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. Dive deeper into the earnings by checking this interactive graph of Medpace Holdings's earnings, revenue and cash flow.

A Different Perspective

It's nice to see that Medpace Holdings shareholders have gained 41% (in total) over the last year. That's better than the annualized TSR of 40% over the last three years. The improving returns to shareholders suggests the stock is becoming more popular with time. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - Medpace Holdings has 1 warning sign we think you should be aware of.

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.